Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEUROTECH INTERNATIONAL LIMITED Director's Dealing 2021

May 19, 2021

65449_rns_2021-05-19_b95d3987-fc9b-4c32-860f-ed3f05c8b118.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity NEUROTECH INTERNATIONAL LIMITED ABN 73 6102 054 02

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Allan Cripps
Date of appointment 19 May 2021

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interest.Nil Number & class of SecuritiesNote: aNil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract The Company has agreed to seek shareholderapproval for a grant of 500,000 Class NTIOPT14options ($0.09, expiring 12 May 2023) to AllanCripps (or his nominee).
Nature of interest Direct
Name of registered holder(if issued securities) N/A
No. and class of securities to whichinterest relates Appointment Options:500,000 Class NTIOPT14 options ($0.09,expiring 12 May 2023).
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002